NASDAQ : PRFX
PRF Technologies Ltd. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Israel
Last price 0.7502 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.63M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.55M |
| Enterprise Value | -8.93M |
Dates
| Measure | Value |
|---|
| Earnings Date | Sep 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 3.50M |
| Shares Outstanding | 3.50M |
| Shares Change (YoY) | +229.04% |
| Shares Change (QoQ) | +42.84% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 5.82% |
| Float | 3.30M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 82.41 |
| Forward PS | n/a |
| PB Ratio | 0.14 |
| P/TBV Ratio | 0.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.07 |
| Quick Ratio | 5.00 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -45.33% |
| Return on Assets (ROA) | -21.87% |
| Return on Invested Capital (ROIC) | -26.44% |
| Return on Capital Employed (ROCE) | -31.61% |
| Weighted Average Cost of Capital (WACC) | 9.99% |
| Revenue Per Employee | $4,429 |
| Profits Per Employee | -$759,857 |
| Employee Count | 7 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 10,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -88.41% |
| 50-Day Moving Average | 0.90 |
| 200-Day Moving Average | 1.83 |
| Relative Strength Index (RSI) | 36.64 |
| Average Volume (20 Days) | 34,939 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 19,992 |
| Short Previous Month | 27,647 |
| Short % of Shares Out | 0.57% |
| Short % of Float | 0.61% |
| Short Ratio (days to cover) | 0.06 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 31,000 |
| Gross Profit | -95,000 |
| Operating Income | -5.29M |
| Pretax Income | -5.64M |
| Net Income | -5.32M |
| EBITDA | -4.24M |
| EBIT | -5.29M |
| Loss Per Share | -$5.00 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 11.54M |
| Total Debt | 50,000 |
| Net Cash | 11.49M |
| Net Cash Per Share | $3.28 |
| Equity (Book Value) | 16.48M |
| Book Value Per Share | 5.22 |
| Working Capital | 9.54M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -4.41M |
| Capital Expenditures | -4,000 |
| Depreciation & Amortization | 1.06M |
| Net Borrowing | n/a |
| Free Cash Flow | -4.41M |
| FCF Per Share | -$1.26 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | -17,077.42% |
| Pretax Margin | -18,187.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -229.04% |
| Shareholder Yield | -229.04% |
| Earnings Yield | -684.31% |
| FCF Yield | -172.66% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 1,198.97% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Feb 6, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -4.42 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |